Questcor buys API specialist BioVectra for $51m
January 8, 2013Manufacturing and Production API, Achtar, BioVectra, Questcor
US biopharma firm Questcor has signed a deal to acquire Canadian active pharmaceutical ingredient (API) manufacturer BioVectra for an upfront …
Boehringer hands back Lilly drug
January 8, 2013Research and Development, Sales and Marketing Boehringer, Tradjenta, diabetes, lilly
Boehringer Ingelheim has handed back one of Eli Lilly’s investigational diabetes drugs as a result of ‘independent strategic portfolio considerations’. …
Valeant shuts plant in Brazil, second to follow
January 8, 2013Manufacturing and Production Brazil, Medicis, Valeant
Canadian firm Valeant Pharmaceuticals has closed down one of its facilities in Brazil and will shutter a second in the …
Eisai and Novartis part ways
January 8, 2013Sales and Marketing COPD, Eisai, Novartis, Onbrez, Spiriva
Novartis and Eisai have abandoned their co-promotion agreement for three of Novartis’ chronic obstructive pulmonary disease treatments. The move follows …
Novo Nordisk appoints Curtis Oltmans to US executive team
January 8, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novo Nordisk, Oltmans
Novo Nordisk has announced that Curtis Oltmans has been promoted to corporate vice president and general counsel, Legal and Quality …
Marketing excellence: how to win over your internal audience
January 7, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing MSI, Manastersky, marketing
You’ve spent months building a marketing excellence training curriculum which has been prioritised by marketing leadership as a critically important …
David Cook appointed chief financial officer of Biotie
January 7, 2013Manufacturing and Production, Research and Development, Sales and Marketing Biotie, David Cook
David Cook has been appointed chief financial officer (CFO) of drug development firm Biotie Therapies and will become a member …
AbbVie splits from Abbott
January 7, 2013Sales and Marketing AbbVie, Abbott, HIV, Humira
AbbVie, the new $18 billion biopharma company which includes many of Abbott’s most high profile products, has finally launched. Abbott …
Pressure on pharma M&A
January 7, 2013Research and Development, Sales and Marketing Ernst & Young, M&A, MA, mergers
The world’s largest pharma companies will be under greater pressure to merge with or purchase other firms over the next …
New price and data changes NICE view on Lucentis
January 4, 2013Sales and Marketing Bayer, Eylea, Lucentis, NICE, Novartis
A new lower price and new data analysis has persuaded NICE to recommend Lucentis for patients with diabetic macular oedema …
Celgene appoints new Human Resources director
January 2, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Celgene
Celgene has announced the appointment of Sarah Bater as director of Human Resources, Celgene UK and Ireland. Bater brings a wealth …
Contract research news in brief
December 21, 2012Research and Development Almac, Clinipace, Harrison Clinical Research, PRA, Quintiles, Synteract, WuXi PharmaTech
Synteract agrees to by Harrison Clinical Research, WuXi forges JV with PR, plus appointments and a new accreditation for Quintiles’ …
Pharma manufacturing news in brief
December 21, 2012Manufacturing and Production Amarin, BASF, Bioden Idec, Eisai, Lonza, Patheon, Sartorious Stedim Biotech, banner pharmacaps
BASF extends offer for ProNova, Patheon closes Banner Pharmacaps deal, plus updates from Amarin, Biogen Idec/Eisai and Lonza.
DH digital strategy released
December 21, 2012Medical Communications DH, NHS, digital
The Department of Health has signalled its desire to make a splash in the digital pond with the release of …
Gerresheimer buys Indian pharma packaging specialist
December 21, 2012Manufacturing and Production Gerresheimer, Triveni
Glass and plastic packaging specialist Gerresheimer has acquired a majority stake in Indian company Triveni Polymers Pvt in a bid …
Merck KGaA pipeline hit
December 21, 2012Research and Development, Sales and Marketing Cancer, Merck KGaA, NSCLC, pipeline
Merck KGaA’s pipeline has been dented by the ‘disappointing’ late-stage failure of Stimuvax in a programme with non-small cell lung …
NHS blueprint under fire
December 20, 2012Sales and Marketing CB, CCGs, Labour, NHS
The NHS Commissioning Board’s blueprint for care has promised extra funds for health providers and greater transparency for patients. Board …
Sanofi global operations president to retire
December 20, 2012Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Hanspeter Spek, Sanofi
Sanofi has announced that Hanspeter Spek, president, Global Operations, will retire from his current role in mid-2013. Christopher Viehbacher, chief executive …
Mixed response to ‘seven-day’ NHS
December 20, 2012Sales and Marketing BMA, CCGs, NHS, RCP
The NHS’s possible move to seven-day working has received a mixed welcome, with the BMA dubbing the proposals ‘too crude’. …
$700m fines for Amgen
December 20, 2012Manufacturing and Production, Sales and Marketing Amgen, FDA, off label, off-label
Amgen has pleaded guilty to misbranding its anaemia drug Aranesp following a string of US lawsuits against the biotech company. The …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
